Connect with us

Hi, what are you looking for?

Local News

Road to new Alzheimer’s treatment isn’t a straight path, Vanderbilt doctor says

The news of the second drug to fight Alzheimer’s disease approved by the FDA — the first one to get Full FDA approval — is a good sign according to Paul Newhouse, the director of the Vanderbilt Center for Cognitive Medicine.

Loading

Comments

You May Also Like

Advertisement
Back